Therefore, our study indicates MOB2 as an endogenous master upstream inhibitor in the FAK/Akt pathway in GBM cells and low levels of MOB2 protein may serve as a predictive biomarker for FAK activation and inhibitor sensitivity in GBM. Here, PTK2 is linked to glioblastoma.